Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.96 |
| ▸ | MEN1 | O00255 | 2/20 | 0.92 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.92 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.92 |
| ▸ | ATM | Q13315 | 1/20 | 0.68 |
| ▸ | GNAI3 | P08754 | 9/20 | 0.68 |
| ▸ | GNAI1 | P63096 | 9/20 | 0.68 |
| ▸ | GNAO1 | P09471 | 8/20 | 0.64 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27508518 | 1.00 | L3MBTL1 (0.96) | L3MBTL1MEN1KMT2ATDP1ATM | |
| N-(Decanoyl)Pyrrolidine SCHEMBL10755236 | 1.00 | L3MBTL1 (0.96) | L3MBTL1MEN1KMT2ATDP1ATM | |
| SCHEMBL28152342 | 1.00 | L3MBTL1 (0.96) | L3MBTL1MEN1KMT2ATDP1ATM | |
| SCHEMBL10534175 | 1.00 | L3MBTL1 (0.96) | L3MBTL1MEN1KMT2ATDP1ATM | |
| SCHEMBL10534171 | 1.00 | L3MBTL1 (0.96) | L3MBTL1MEN1KMT2ATDP1ATM | |
| SCHEMBL10494122 | 1.00 | L3MBTL1 (0.96) | L3MBTL1MEN1KMT2ATDP1ATM | |
| SCHEMBL151361 | 1.00 | L3MBTL1 (0.96) | L3MBTL1MEN1KMT2ATDP1ATM | |
| N-(Decanoyl)Pyrrolidine SCHEMBL692598 | 1.00 | L3MBTL1 (0.96) | L3MBTL1MEN1KMT2ATDP1ATM | |
| SCHEMBL249052 | 1.00 | L3MBTL1 (0.96) | L3MBTL1MEN1KMT2ATDP1ATM | |
| SCHEMBL28149836 | 1.00 | L3MBTL1 (0.96) | L3MBTL1MEN1KMT2ATDP1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1569831-A | Phenol-containing wastewater extraction agent N-octanoyl pentazane and its synthesis method | UNIV SHANGHAI (CN) | 2005-01-26 | — | — | CN | claimed |
| US-20250361234-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS | NICO THERAPEUTICS INC (US) | 2025-11-27 | — | — | US | disclosed |
| US-20240410034-A1 | CYCLIC AMINE MONOAMIDES FOR EXTRACTING URANIUM(VI) AND PLUTONIUM(IV) AND FOR SEPARATING THEM WITHOUT REDUCING PLUTONIUM(IV) | Commissariat à l'énergie atomique et aux énergies alternatives (FR) | 2024-12-12 | — | — | US | disclosed |
| CN-118354828-A | Cyclic amine monoamides for extracting uranium (VI) and plutonium (IV) and for separating them without reduction of the plutonium (IV) | 原子能与替代能源委员会 | 2024-07-16 | — | — | CN | disclosed |
| WO-2023067273-A1 | CYCLIC AMINE MONOAMIDES FOR THE EXTRACTION OF URANIUM(VI) AND PLUTONIUM(IV) AND FOR THE SEPARATION THEREOF WITHOUT REDUCTION OF THE PLUTONIUM(IV) | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2023-04-27 | — | — | WO | disclosed |
| CN-111995152-B | Method for treating high-concentration wastewater generated in synthesis of anisole from methyl sodium sulfate waste residues | 浙江大洋生物科技集团股份有限公司 | 2022-05-13 | — | — | CN | disclosed |
| US-10441581-B2 | Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors | ARRAY BIOPHARMA INC. (US) | 2019-10-15 | — | — | US | disclosed |
| US-20180133207-A1 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS | ARRAY BIOPHARMA INC. | 2018-05-17 | — | — | US | disclosed |
| US-9671415-B2 | Immunoassay for pyrrolidinophenones | RANDOX LABORATORIES LIMITED (GB) | 2017-06-06 | — | — | US | disclosed |
| US-20160097783-A1 | IMMUNOASSAY FOR PYRROLIDINOPHENONES | NORTHERN BANK LIMITED (IE) | 2016-04-07 | — | — | US | disclosed |
| US-9012690-B2 | Method for producing alcohol and/or amine from amide compound | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-04-21 | — | — | US | disclosed |
| US-20130172619-A1 | METHOD FOR PRODUCING ALCOHOL AND/OR AMINE FROM AMIDE COMPOUND | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-07-04 | — | — | US | disclosed |
| CN-102976561-A | Technique for treating phenol/anisole-containing production wastewater | UNIV TIANJIN POLYTECHNIC | 2013-03-20 | — | — | CN | disclosed |
| US-20120041190-A1 | MACROCYCLES AS FACTOR XIA INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2012-02-16 | — | — | US | disclosed |
| CN-1569831-A | Phenol-containing wastewater extraction agent N-octanoyl pentazane and its synthesis method | UNIV SHANGHAI (CN) | 2005-01-26 | — | — | CN | disclosed |
| US-4837026-A | Transdermal and systemic preparation and method | THERAPEUTIC PATCH RESEARCH N.V. | 1989-06-06 | — | — | US | disclosed |
| EP-0240554-A1 | TRANSDERMAL AND SYSTEMIC PREPARATION AND METHOD | RAJADHYAKSHA, Vithal J. (US) | 1987-10-14 | — | — | EP | disclosed |
| WO-1987001935-A1 | TRANSDERMAL AND SYSTEMIC PREPARATION AND METHOD | RAJADHYAKSHA VITHAL J | 1987-04-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120041190-A1 | MACROCYCLES AS FACTOR XIA INHIBITORS | TFPI, TFPI2, F11 | L3MBTL1 4750/4885MEN1 376/4885KMT2A 1111/4885 |
| US-20240410034-A1 | CYCLIC AMINE MONOAMIDES FOR EXTRACTING URANIUM(VI) AND PLUTONIUM(IV) AND FOR SEPARATING THEM WITHOUT REDUCING PLUTONIUM(IV) | PADI2, PADI4, PADI1 | L3MBTL1 3340/4885MEN1 1395/4885KMT2A 1009/4885 |
| US-20250361234-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS | SARM1, SARS1, TIAM1 | L3MBTL1 1416/4885MEN1 1134/4885KMT2A 3835/4885 |
| US-20130172619-A1 | METHOD FOR PRODUCING ALCOHOL AND/OR AMINE FROM AMIDE COMPOUND | ADH1A, ADH1C, ADH5 | L3MBTL1 1593/4885MEN1 2754/4885KMT2A 909/4885 |
| US-20160097783-A1 | IMMUNOASSAY FOR PYRROLIDINOPHENONES | CYP2D6, CYP2B6, CYP3A43 | L3MBTL1 4860/4885MEN1 3835/4885KMT2A 4554/4885 |
| US-10441581-B2 | Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors | RET, BRAF, RAF1 | L3MBTL1 2011/4885MEN1 653/4885KMT2A 1112/4885 |
| US-20180133207-A1 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS | RET, BRAF, RAF1 | L3MBTL1 2011/4885MEN1 653/4885KMT2A 1112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.